Sputnik V in India: Dr Reddy's to begin supply of COVID-19 vaccine imported from Russia in May

Sputnik V in India: Dr Reddy's to begin supply of COVID-19 vaccine imported from Russia in May

Drug major Dr Reddy's Laboratories is also going to tap domestically sourced jabs as their production speeds up in India

Advertisement
Talks between the Centre and the Hyderabad-based drug major are on. Dr Reddy's is the sole licensing partner for Sputnik V in IndiaTalks between the Centre and the Hyderabad-based drug major are on. Dr Reddy's is the sole licensing partner for Sputnik V in India
BusinessToday.In
  • Apr 14, 2021,
  • Updated Apr 14, 2021 4:19 PM IST

Dr Reddy's Laboratories will begin supplying Sputnik V coronavirus vaccines, imported from Russia, in May. The drug major is also going to tap domestically sourced jabs as their production speeds up in India.

However, the vaccine's pricing, along with how many doses will be supplied at the outset, has not been determined yet.

Advertisement

Meanwhile, talks between the Centre and the Hyderabad-based drug major are on. Dr Reddy's is the sole licensing partner for Sputnik V in India.

Also Read:

India is the most populated country to register the vaccine and is also the leading production hub for Sputnik V, it added.

In September 2020, Dr Reddy's had partnered with the Russian Direct Investment Fund (RDIF) to conduct clinical trials of Sputnik V and distribute the vaccine in India.

In addition to the trials conducted in Russia by RDIF, phase II/III clinical trials of the vaccine were carried out by Dr Reddy's in India.

Dr Reddy's Laboratories will begin supplying Sputnik V coronavirus vaccines, imported from Russia, in May. The drug major is also going to tap domestically sourced jabs as their production speeds up in India.

However, the vaccine's pricing, along with how many doses will be supplied at the outset, has not been determined yet.

Advertisement

Meanwhile, talks between the Centre and the Hyderabad-based drug major are on. Dr Reddy's is the sole licensing partner for Sputnik V in India.

Also Read:

India is the most populated country to register the vaccine and is also the leading production hub for Sputnik V, it added.

In September 2020, Dr Reddy's had partnered with the Russian Direct Investment Fund (RDIF) to conduct clinical trials of Sputnik V and distribute the vaccine in India.

In addition to the trials conducted in Russia by RDIF, phase II/III clinical trials of the vaccine were carried out by Dr Reddy's in India.

Read more!
Advertisement